Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
After finishing at $2.59 in the prior trading day, Larimar Therapeutics Inc (NASDAQ: LRMR) closed at $2.55, down -1.54%. In other words, the price has decreased by -$1.54 from its previous closing price. On the day, 1.05 million shares were traded. LRMR stock price reached its highest trading level at $2.6353 during the session, while it also had its lowest trading level at $2.5.
Ratios:
Our goal is to gain a better understanding of LRMR by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.10 and its Current Ratio is at 13.10. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Truist on January 29, 2025, initiated with a Buy rating and assigned the stock a target price of $18.
On October 16, 2024, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $26.
On October 03, 2024, Wedbush started tracking the stock assigning a Outperform rating and target price of $22.Wedbush initiated its Outperform rating on October 03, 2024, with a $22 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LRMR now has a Market Capitalization of 162706832 and an Enterprise Value of -35638100.
Stock Price History:
The Beta on a monthly basis for LRMR is 0.83, which has changed by -0.7031432 over the last 52 weeks, in comparison to a change of 0.09589827 over the same period for the S&P500. Over the past 52 weeks, LRMR has reached a high of $11.20, while it has fallen to a 52-week low of $2.52. The 50-Day Moving Average of the stock is -23.16%, while the 200-Day Moving Average is calculated to be -60.39%.
Shares Statistics:
The stock has traded on average 737.50K shares per day over the past 3-months and 654590 shares per day over the last 10 days, according to various share statistics. A total of 63.81M shares are outstanding, with a floating share count of 36.46M. Insiders hold about 42.86% of the company’s shares, while institutions hold 59.26% stake in the company. Shares short for LRMR as of 1740700800 were 5089276 with a Short Ratio of 6.90, compared to 1738281600 on 5070734. Therefore, it implies a Short% of Shares Outstanding of 5089276 and a Short% of Float of 12.21.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
The performance of Larimar Therapeutics Inc (LRMR) in the stock market is under the watchful eye of 10.0 analysts actively contributing to its current rating.The consensus estimate for the next quarter is -$0.37, with high estimates of -$0.3 and low estimates of -$0.5.
Analysts are recommending an EPS of between -$1.11 and -$1.49 for the fiscal current year, implying an average EPS of -$1.22. EPS for the following year is -$1.66, with 9.0 analysts recommending between -$1.26 and -$2.2.
